New gel aims to reignite sexual arousal in women
NCT ID NCT06651541
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This Phase 2 study tests a gel called BZ371A on 174 women with sexual arousal disorder. The gel is applied before sexual activity to see if it increases arousal, desire, and lubrication compared to a placebo. The goal is to find a safe and effective option for women struggling with arousal.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
BZ371A gel
What this could lead to
If successful, this gel could offer a new topical treatment to help women with sexual arousal disorder experience increased arousal during sexual activity.
What could go wrong
This is an early Phase 2 trial with only 174 participants, so results may not confirm effectiveness or safety. The placebo effect is also a factor in sexual health studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FEMALE SEXUAL AROUSAL DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ambulatório Jenny Farias do Hospital das Clínicas da UFMG
Belo Horizonte, Brazil
Contact Phone: •••-•••-••••